Analystreport

REDHILL BIOPHAR/S (NASDAQ: RDHL) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations